Factor X Deficiency
A rare inherited disorder of the common coagulation pathway caused by mutations in the F10 gene, resulting in bleeding tendencies ranging from mild bruising to severe hemorrhage.
- Autosomal Recessive Inheritance
- Common Pathway Factor
- Specialist Hematology Care
- Estimated Prevalence
- ~1 in 1,000,000
- Inheritance Pattern
- Autosomal Recessive
- Gene Involved
- F10
- Care Access
- Specialist Hematology & Factor Therapy
Condition Overview
Factor X deficiency is a rare hereditary coagulation disorder caused by mutations in the F10 gene. Factor X sits at a critical junction in the clotting cascade, where the extrinsic and intrinsic pathways converge into the common pathway that ultimately generates thrombin and a stable fibrin clot.
Because of its central role, deficiency in Factor X can affect clotting regardless of which pathway initiates it, which is why bleeding tendencies in this condition can be more pronounced than in deficiencies further upstream. The disorder is inherited in an autosomal recessive pattern, and severity correlates broadly with residual factor activity, though clinical bleeding patterns can vary even among individuals with similar lab values.
Acquired Factor X deficiency, distinct from the inherited form, can occur in association with systemic amyloidosis, where the protein is absorbed onto amyloid fibrils, as well as with liver disease or vitamin K deficiency.
Types and Variants
Factor X deficiency is classified by severity of factor activity reduction and by congenital versus acquired origin.
Symptoms and Signs
Symptom severity in Factor X deficiency tends to track closely with the degree of factor reduction, though presentation varies.
Causes and Risk Factors
Factor X deficiency arises from inherited gene mutations or, less commonly, from acquired conditions that impair factor production or function.
Diagnosis and Investigations
Diagnosis combines coagulation screening, specific factor assays, and evaluation for underlying acquired causes when relevant.
Severity Classification
Factor X deficiency is classified by residual factor activity level rather than staged like cancer, guiding bleeding risk assessment and treatment planning.
Standard Treatment Options
Treatment is individualized based on bleeding severity, ranging from observation to factor replacement for active bleeding or procedural prophylaxis.
Advanced and Emerging Therapies
Specific Factor X concentrates and ongoing research into longer-acting products are expanding options for this rare disorder.
Plasma-Derived Factor Replacement
Plasma-Derived Factor X Concentrate
A purified, virus-inactivated product specifically developed for Factor X deficiency, offering more targeted replacement than general plasma products.
Gene Therapy Research
Investigational Gene Replacement Approaches
Early research exploring gene-based correction strategies for rare coagulation factor deficiencies.
Specialist Hematology Access
Cross-Border Specialist Coordination
Connection to comprehensive bleeding disorder treatment centers for complex case management.
Biomarkers and Laboratory Monitoring
Targeted laboratory monitoring supports diagnosis, severity classification, and treatment response assessment.
When a Second Opinion May Be Important
Given the rarity and complexity of Factor X deficiency, specialist review can be especially valuable at key decision points.
Clinical Trials and Research
Prognosis and Outlook
Outcomes for Factor X deficiency depend heavily on severity, access to specialist care, and consistency of preventive management.
Supportive Care and Living With Factor X Deficiency
Coordinated, practical care helps reduce bleeding risk and supports day-to-day wellbeing for people living with Factor X deficiency.
How CancerFax Helps You Explore Treatment Options
CancerFax helps patients with Factor X deficiency access specialist hematology review, coordinate second opinions on complex management plans, and connect with comprehensive bleeding disorder treatment centers internationally.
Get a free case reviewFrequently Asked Questions
Factor X deficiency is a rare inherited bleeding disorder caused by mutations in the F10 gene, reducing the activity of a protein essential to the common pathway of blood clotting.
Because Factor X sits at the convergence point of the clotting cascade, its deficiency can affect clot formation regardless of which pathway is triggered, sometimes leading to more pronounced bleeding.
It typically follows an autosomal recessive pattern, requiring mutations in both copies of the F10 gene for significant symptoms.
Yes, acquired forms can occur with systemic amyloidosis, liver disease, or vitamin K deficiency, distinct from the inherited genetic condition.
Easy bruising, prolonged bleeding from minor cuts, heavy menstrual bleeding, and frequent nosebleeds are common early signs prompting evaluation.
Plasma-derived Factor X concentrate is the preferred treatment for active bleeding or before procedures, with alternatives used when unavailable.
Severe deficiency can present with umbilical stump bleeding in newborns and requires prompt hematology evaluation.
Yes, with careful perioperative planning and factor replacement coordinated by a hematology specialist.
Genetic counseling and testing can help identify carriers or affected relatives, particularly in families with known mutations.
Yes. CancerFax helps patients with Factor X deficiency get their medical reports reviewed by specialists, coordinate second opinions, and connect with comprehensive bleeding disorder centers and advanced therapy access internationally.
Get Expert Guidance for Factor X Deficiency
Send your medical reports for specialist hematology review and explore coordinated care options.